George Putnam
The Turnaround Letter
Geoffrey Seiler
Bullmarket.com
Chuck Carlson
The DRIP Investor
Nicholas Vardy
Bull Market Alert

Adens stick with gold


Bookmark and Share

 "Despite recent gains gold is not yet overbought and the current rise is likely headed higher," say resource experts Mary Anne and Pamela Aden. Here's their latest from The Aden Forecast.

"Gold recently hit another new record high. Its recent strength was clearly propelled gold by the news that India bought 200 tons of the IMF's gold (half of what it's planning to sell) at these high price.

Advertisement
Banner

"That action, in one fell swoop, was incredibly bullish. It was viewed as a strong sign that gold is not too expensive and the Indians, who have a long gold history, obviously believe it's going high.

"Interestingly, our leading indicators continue reinforcing this as well. Technically, despite gold's ongoing C rise, its key indicator has not yet reached the temporarily too high area, which coincided with the previous A and C intermediate highs in the gold price. 

"In other words, gold is not yet overbought and the current rise is likely headed higher. As long as this continues and gold stays above $1000 our next target for gold at $1200 is looking more realistic.

"Rising gold and the Fed's pledge to keep interest rates near zero, probably into next year, has been the main reason behind the dollar's weakness. 

"This will keep downward pressure on the dollar in the months ahead, especially combined with the dollar's bearish fundamentals. The dollar index will now remain weak below 76 and a further decline would be underway below 75. 

"Hold onto your gold, silver and gold shares. Gold is now stronger than silver and gold shares; therefore, buy new positions in gold only. Our recommended gold position remains SPDR Gold Shares (NYSE: GLD)."


News Flash

Goldcorp: 'My favorite major'
by Curtis Hesler, editor Professional Timing Service

The secular bull in gold and the commodity sector is not over. However, it is not at the ground floor any longer either; as such, stock selection must be more carefully considered.


Read more...

 

Money manager's small cap buys
by Jim Oberweis Jr., editor The Oberweis Report

Small-cap growth stock valuations are cheap, and like most things in life, economies are cyclical, even if this is a long and painful one. For the rare, brave contrarian with a reasonably long time horizon, that spells opportunity.


Read more...


   

Opportunities in homebuilding?
by Bernie Schaeffer, editor Schaeffer's Investment Research

Based on our "expectational analysis" strategy -- which  combines fundamental, sentiment and technical metrics -- I initiated long positions in two homebuilding stocks: Lennar Corporation (LEN) and Toll Brothers (TOL).


Read more...

 

Cliffs Natural: A DRIP favorite
by Vita Nelson, editor MoneyPaper

Our latest featured dividend reinvestment stock is Cliffs Natural Resources (CLF). Founded in 1847, the former Cleveland-Cliffs is the largest producer of iron ore pellets in North America.


Read more...

 

S&P's trio of info tech ETFS
by Dylan Cathers, S&P Capital IQ Equity Analyst, S&P The Outlook

Information technology is one of four sectors that S&P Capital IQ’s Sector Strategy Group currently recommends investors overweight in their portfolios.


Read more...

 

Crescent Point: Bakken bet
by Brian Hicks, editor Wealth Advisory

Master Limited Partnerships (MLPs) are unique investments that combine the tax benefits of a limited partnership (LP) with the liquidity of common stock.


Read more...

 

Natural gas: A bottom?
by Jason Cimpl, editor Daily Profit

Natural gas has collapsed for the past four years and has been on a gradual decline for almost a decade. Prices topped near $16 in 2005 and then declined to $2. So did natural gas just bottom?


Read more...

 

FBR Focus bests 99% of peers
by Walter Frank, editor MoneyLetter

Funds that invest in a relatively few stocks or sectors are less diversified than broadly invested funds and their volatility can be much higher. But the team at FBR Focus (FBRVX) seems to be getting it right.


Read more...

 

Celgene: Catalysts ahead
by John McCamant, editor Medical Technology Stock Letter

Celgene (CELG) recently kicked off the 2012 JP Morgan Healthcare conference by pre-announcing 4Q11 results and providing 2012 guidance.


Read more...

 

Water, water
by Richard Band, editor Profitable Investing

In the current environment, investors should focus any new stock purchases on companies with recession-resistant franchises and generous dividends -- such as water utilities.


Read more...